Healthcare groups decry CDC messaging change on autism and vaccines
Mackenzie Bean / beckershospitalreview - Healthcare associations are raising concerns after the CDC this week removed messaging from its website stating that vaccines do not cause autism. The agency updated its webpage on vaccines and autism Nov. 19. Previously, the page said research has shown …
AI Summary: Recent modifications to the CDC’s online vaccine safety pages have alarmed healthcare groups, who contend that altered messaging risks bolstering discredited claims linking vaccines and autism. Critics warn that the move may destabilize public confidence in decades of robust, evidence‐based vaccine research.
Novo Nordisk rolls out lower prices for Ozempic and Wegovy
medicalxpress - People paying out of pocket for Ozempic or Wegovy may soon see lower costs, as Novo Nordisk rolls out new price discounts for its popular GLP-1 medications.
AI Summary: In a bid to ease the financial burden on self‐pay patients, Novo Nordisk has unveiled deep price cuts for its flagship GLP-1 drugs, Ozempic and Wegovy. The new pricing strategy comes amid intensifying market pressures and aims to broaden access to these critical therapies for weight management and type 2 diabetes.
ESMO AI & Digital Oncology Congress 2025 Closed in Berlin under the Promise of Making the Future of Cancer Care Closer
esmo - The European Society for Medical Oncology (ESMO) has just closed its first AI & Digital Oncology Congress, a pioneering moment in the integration of artificial intelligence and digital innovation into cancer care
AI Summary: The first edition of the ESMO AI & Digital Oncology Congress in Berlin has concluded, spotlighting breakthroughs in computational pathology, transformative AI applications and reimagined cancer care. Despite the inevitable buzzwords, attendees proved data and innovation aren’t just hype—they’re reshaping oncology with a knowing smirk.
Mikael Dolsten removes himself from board candidacy at Novo; Bavarian Nordic chairman resigns
Alex Hoffman / endpoints - → In what appears to be another blow to Novo Nordisk, ex-Pfizer CSO Mikael Dolsten has withdrawn his nomination to join the company's board of directors due to ...
AI Summary: Merck has made a blockbuster move by finalizing a $9.2 billion deal to acquire Cidara Therapeutics’ late‐stage anti‐influenza candidate. This acquisition underscores Merck’s commitment to expanding its antiviral portfolio and marks a key strategic investment in advancing flu prevention amid evolving global health threats.
F.D.A. Will Remove Black Box Warnings From Hormone Treatments for Menopause
Roni Caryn Rabin / nytimes - The benefits of hormone replacement have been underappreciated, Dr. Marty Makary, the agency’s commissioner, said on Monday. Critics described evidence for the change as insufficient.
AI Summary: In a bold policy pivot, the FDA will lift long‑standing black box warnings on hormone treatments for menopause. The decision – made without an official advisory committee’s input – updates labeling to better reflect current risk–benefit assessments, leaving critics to wonder if caution has finally given way to progress.
FDA adds strongest warning to Sarepta gene therapy linked to 2 patient deaths
go - The Food and Drug Administration is adding a new warning to a gene therapy linked to two patient deaths earlier this year
AI Summary: The FDA has revised the label for Sarepta’s Duchenne muscular dystrophy gene therapy, adding a boxed safety warning and stricter usage conditions following reports of two patient deaths. The update reflects mounting safety concerns that have prompted closer regulatory oversight.
Bacteria Inside Brain Tumors May Affect Tumor Behavior
oncodaily - Traces of bacteria inside brain tumors may affect tumor behavior Researchers found bacterial genetic and cellular elements inside brain tumor cells that appear biologically active and may influence tumor progression […]
AI Summary: Researchers discovered unexpected traces of bacteria within brain tumors, suggesting these microbial signals might influence tumor progression. The findings, detailed in two nearly identical reports, could open new avenues for targeted therapies and a deeper understanding of the tumor microenvironment.
Scientists document a death from a meat allergy tied to certain ticks
go - Researchers are reporting what they believe is the first documented death from a meat allergy triggered by tick bites
AI Summary: Researchers have reported what appears to be the first documented death from a meat allergy triggered by a tick bite. The case, involving a New Jersey patient, raises startling questions about the potential dangers of tick-related food allergies and underscores the urgent need for heightened awareness and additional scientific investigation.
Preliminary case of bird flu in Washington state would be U.S.'s first in 9 months
medicalxpress - Health officials in Washington state say they have identified the nation's first human case of bird flu since February, pending confirmatory testing.
AI Summary: Washington state health officials have confirmed a human case of bird flu—the first reported since February—raising concerns as confirmatory testing is underway. The reports, though phrased slightly differently, all describe this singular event and underline the ongoing surveillance amid unusual viral activity.
Historic government shutdown ends, leaving ACA subsidies in limbo
Rebecca Pifer / healthcaredive - The House passed a stopgap funding bill and President Donald Trump signed it late Wednesday, reopening the government without a clear path forward on preserving enhanced subsidies for ACA plans — Democrats’ chief demand.
AI Summary: Following the end of the longest government shutdown in U.S. history, healthcare organizations are calling on lawmakers to secure critical ACA premium tax credits and subsidies, even as government functions resume. Despite reopening, key funding mechanisms remain unresolved—leaving consumers, insurers, and industry experts in a state of cautious uncertainty.
Infant Formula Recall Expands as Botulism Outbreak Grows
Rylee Kirk / nytimes - Federal health officials said caregivers should stop using all ByHeart powdered formula products after 15 infants in 12 states were hospitalized.
AI Summary: ByHeart, a maker of organic baby formula, has expanded its nationwide recall after several infants were hospitalized with botulism symptoms. Federal health officials are urging caregivers to stop using all ByHeart powdered formula as investigations into the contamination continue.
Richard Pazdur Appointed Director of the FDA’s Drug Center: A New Chapter for Cancer Regulation
oncodaily - Dr. Richard Pazdur, one of the most influential figures in oncology drug regulation, has been appointed Director of the U.S. Food and Drug Administration’s (FDA) Center for Drug Evaluation and […]
AI Summary: The FDA has ushered in a new era in oncology drug oversight by appointing Dr. Richard Pazdur as the director of its Drug Center. The move comes amid agency challenges and staff cuts, promising stabilizing leadership at one of its most influential divisions.
Canada loses measles elimination status after ongoing outbreaks
go - International health experts say Canada is no longer measles-free because of ongoing outbreaks, as childhood vaccination rates fall and the highly contagious virus spreads across North and South America
AI Summary: Health experts report that Canada has lost its measles elimination status amid large-scale outbreaks and falling vaccination rates. The loss, confirmed by multiple sources, has raised public health alarms and may affect regional disease control efforts.
FDA rolls back warning labels on HRT products for menopause, citing misinformation
fiercehealthcare - The action, announced Monday, follows a comprehensive review of scientific literature by an expert panel at the agency in July, as well as a public comment period, officials said. Pharmas are expected to update and reprint their product labeling to remove…
AI Summary: Following a rigorous review of the scientific evidence, federal regulators are scrapping boxed warnings on hormone replacement products used for menopausal symptom relief. The move—aimed at increasing treatment access—casts a skeptical eye on long-held safety fears, inviting both applause and a few sarcastic raised eyebrows in the industry.
Infant Formula Recalled Amid Botulism Investigation
Amanda Holpuch / nytimes - Health agencies asked caregivers to stop using two batches of ByHeart Whole Nutrition Infant Formula after they found an increase in cases of infant botulism.
AI Summary: Health authorities have issued an urgent recall of specific infant formula batches following a surge in botulism cases across multiple states. Caregivers are advised to stop using the affected products while a thorough investigation is underway to safeguard infant health.
Pfizer’s Sweeter $10B Offer Beats Novo Nordisk in Bidding War for Obesity Biotech Metsera
Frank Vinluan / medcitynews - Pfizer’s offer of up to $86.25 in cash for each share of obesity drugs developer Metsera share tops the up to $86.20 Novo Nordisk was willing to pay. The financial consideration and the greater certainly of a deal close tipped the balance in Pfizer’s favo…
AI Summary: In a dramatic showdown over obesity biotech firm Metsera, Pfizer’s up-to-$10B cash offer edged out Novo Nordisk’s bid. The fiercely competitive deal highlights the high stakes and intense market focus on innovative therapeutics in obesity management.
<![CDATA[Younger Age at Glomerular Disease Diagnosis Linked to Greater Lifetime Risk Despite Similar Progression Rates]]>
hcplive -
AI Summary: New research finds that patients diagnosed with glomerular disease at a younger age face a markedly higher lifetime risk—even though progression rates appear similar to those seen in older patients. The study challenges conventional views on early‑onset kidney disease.
Pfizer poised to buy Metsera in $10 bn deal after bidding war
medicalxpress - Pfizer was poised to seal a takeover of Metsera on Saturday after its improved offer won over the biotechnology startup's board and Danish challenger Novo Nordisk called a halt to a back-and-forth bidding war.
AI Summary: In a dramatic bidding war for a promising biotech startup, Pfizer’s improved $10 billion offer prevailed—until Novo Nordisk raised its bid yet again. This high-stakes takeover tussle underscores the fierce competition and strategic importance of emerging therapies.
Intensive blood pressure lowering could benefit almost all adults with hypertensive chronic kidney disease
medicalxpress - An analysis of the Systolic Blood Pressure Intervention Trial (SPRINT) indicates that nearly all adults with chronic kidney disease (CKD) would have benefits that outweigh the harm from a systolic blood pressure target of
AI Summary: New analysis rooted in the SPRINT study shows that nearly all adults with chronic kidney disease related to high blood pressure may benefit from lower targets. Experts argue this calls for revisiting longstanding guidelines in blood pressure management.
#AHA25: Amgen’s cholesterol drug cuts first-time cardiovascular events by a quarter
Elizabeth Cairns / endpoints - Amgen on Saturday said its cholesterol-lowering drug Repatha cut cardiovascular events by 25% when added on top of standard therapy in high-risk patients who have never had a heart attack or stroke. Repatha is already ...
AI Summary: At AHA25 in New Orleans, researchers and clinicians showcased pivotal findings – including Amgen’s cholesterol‐lowering drug cutting first‐time cardiovascular events by 25% – while experts like Avirup Guha highlighted innovative cardio‐oncology sessions. The event spotlighted the evolving intersection between heart health and cancer care.